ScholarIQanswers from OpenAlex

Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target

PaperCitations, authors & open-access status

Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target have?

ScholarIQcitation count

Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target has 62 citations in the OpenAlex counts ScholarIQ stores.

When was Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target published?

ScholarIQyear

Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target has 2019 year in the ScholarIQ index.

What is the open-access status of Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target?

ScholarIQoa status

Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target has closed oa status in the ScholarIQ index.

What is the DOI of Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target?

ScholarIQdoi

The DOI for Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target is on the source record.

What is the PMID of Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target?

ScholarIQpmid

The PMID for Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target is on the source record.

What is the OpenAlex record for Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target?

ScholarIQopenalex

The OpenAlex for Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial